1. Home
  2. AWI vs KYMR Comparison

AWI vs KYMR Comparison

Compare AWI & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AWI

Armstrong World Industries Inc

HOLD

Current Price

$193.34

Market Cap

8.0B

Sector

Industrials

ML Signal

HOLD

Logo Kymera Therapeutics Inc.

KYMR

Kymera Therapeutics Inc.

HOLD

Current Price

$75.25

Market Cap

6.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AWI
KYMR
Founded
1860
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Plastic Products
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
6.4B
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
AWI
KYMR
Price
$193.34
$75.25
Analyst Decision
Buy
Strong Buy
Analyst Count
7
24
Target Price
$203.14
$105.35
AVG Volume (30 Days)
381.9K
1.2M
Earning Date
02-24-2026
02-26-2026
Dividend Yield
0.72%
N/A
EPS Growth
23.00
N/A
EPS
6.97
N/A
Revenue
$1,600,200,000.00
$43,735,000.00
Revenue This Year
$14.13
$18.71
Revenue Next Year
$6.91
N/A
P/E Ratio
$27.18
N/A
Revenue Growth
15.10
N/A
52 Week Low
$122.37
$19.45
52 Week High
$206.08
$103.00

Technical Indicators

Market Signals
Indicator
AWI
KYMR
Relative Strength Index (RSI) 55.59 47.34
Support Level $189.08 $69.08
Resistance Level $203.30 $77.75
Average True Range (ATR) 4.63 3.25
MACD 0.47 -1.59
Stochastic Oscillator 50.75 36.28

Price Performance

Historical Comparison
AWI
KYMR

About AWI Armstrong World Industries Inc

Armstrong World Industries Inc. designs, innovates, and manufactures ceiling and wall solutions in the Americas. The company manufactures and sources products made of numerous materials, including mineral fiber, fiberglass, metal, felt, wood, resin, wood fiber, and glass-reinforced-gypsum. It also manufactures ceiling suspension system (grid) products through a joint venture with Worthington Industries, Inc., called Worthington Armstrong Venture (WAVE). The company's reportable operating segments include Mineral Fiber, Architectural Specialties, and Unallocated Corporate. A majority of its revenue is generated from the Mineral Fiber segment, which produces suspended mineral fiber and fiberglass ceiling systems. Geographically, it derives maximum revenue from the United States.

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

Share on Social Networks: